# SPECT/CT in Endocrine and Neuroendocrine Tumors

> **NCT00230139** · NA · COMPLETED · sponsor: **Rambam Health Care Campus** · enrollment: 200 (estimated)

## Conditions studied

- Endocrine and Neuroendocrine Tumors

## Interventions

- **DEVICE:** SPECT/CT

## Key facts

- **NCT ID:** NCT00230139
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2004-01
- **Final completion:** 2006-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2008-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00230139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00230139, "SPECT/CT in Endocrine and Neuroendocrine Tumors". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT00230139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*